Government’s £645m investment pledge is ‘frozen funding’ for next two years, says Labour MP Gardiner


Share post:

Labour MP Barry Gardiner has raised concerns that the £645m cash injection announced by the government for community pharmacy is, in effect, ‘frozen funding’ for the next two years.

Speaking on Tuesday (May 9) on the BBC’s Politics Live, Gardiner said funding for community pharmacies “was cut before 2015, then it was frozen and now the latest announcement says that it’s going to be frozen for a further two years.”

He said with a current national contract, which already represented a 25 per cent funding cut in real terms, it was not appropriate to ask for community pharmacy “to take on more work” without adequate support.

“I heard the prime minister earlier this morning (May 9) on TV saying ‘we are investing more in pharmacies’.

“No you are not. You just concluded a contract that says for the next two years it will be absolutely flatlined.”

He added that “there will be no more money” for community pharmacy and that steeply rising costs due to inflation were “eating into that contract’s health”.

Gardiner said community pharmacists “do a phenomenal job” but regretted that from a total of just 11,000, some 700 pharmacies have been lost due to funding cuts.

Asked if pharmacists were expected to do more for less, Conservative MP Henry Smith said the focus on supporting pharmacists to help people with minor ailments was “a sensible way forward” and that the move would “certainly help free up GP access”.

Commenting on the £240 million funding to end ‘8am scramble for GP appointments’, he said there was record amount of funding that was going into the National Health Service and that’s why it’s important that a whole range of measures were introduced to “make sure that we have a health system that is reformed and affordable”.


Please enter your comment!
Please enter your name here

Current Issue June 2023

Related articles

MHRA grants authorisation for LEO Pharma’s Adtralza 2 mL pen solution

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the marketing authorisation of Adtralza, a dermatological solution...

Grundon launches maiden UK-wide inhaler recycling programme

Grundon Waste Management has introduced what it claims to be the UK's first verified nationwide inhaler return and...

‘Record fine imposed on hydrocortisone manufacturers for dominant position abuse and 10,000% price increase’

The Competition Appeal Tribunal (CAT) has upheld the Competition and Markets Authority’s (CMA) findings against two pharmaceutical manufacturers...

Vision Report: Legal reforms, adequate funding imperative for success of community pharmacy

Achieving the community pharmacy vision necessitates legal adjustments and additional funding beyond recent boosts, the pharmacy vision document...